Erica L Mayer1. Show Affiliations » 1. Dana-Farber Cancer Institute, Boston, Massachusetts.
Abstract
Entities: Disease
Mesh： See more » Aminopyridines/pharmacologyAminopyridines/therapeutic useAntineoplastic Agents/pharmacologyAntineoplastic Agents/therapeutic useBenzimidazoles/pharmacologyBenzimidazoles/therapeutic useBreast Neoplasms/drug therapyBreast Neoplasms/metabolismBreast Neoplasms/mortalityBreast Neoplasms/pathologyClinical Trials, Phase II as TopicCyclin-Dependent Kinase 4/antagonists & inhibitorsCyclin-Dependent Kinase 6/antagonists & inhibitorsFemaleHumansMolecular Targeted TherapyPiperazines/pharmacologyPiperazines/therapeutic useProtein Kinase Inhibitors/pharmacologyProtein Kinase Inhibitors/therapeutic usePurines/pharmacologyPurines/therapeutic usePyridines/pharmacologyPyridines/therapeutic useReceptors, Estrogen/metabolismResearchTreatment Outcome
Substances： See more » AminopyridinesAntineoplastic AgentsBenzimidazolesPiperazinesProtein Kinase InhibitorsPurinesPyridinesReceptors, EstrogenabemaciclibCyclin-Dependent Kinase 4Cyclin-Dependent Kinase 6palbociclibribociclib
Year: 2015 PMID： 26352578
Source DB: PubMed Journal: Clin Adv Hematol Oncol ISSN： 1543-0790